Whalegun
Home

Ultragenyx Pharmaceutical RARE spent $440K on lobbying in Q1 2026 · Health Issues, Budget and 1 more issue

Trade details

Type
Lobbying report
Amount
$440,000
Quarter
Q1 2026
Stock
Ultragenyx Pharmaceutical RARE
Client
Ultragenyx Pharmaceutical
Reported
26/04/17

Up 238.5% from last quarter

What else happened in Ultragenyx Pharmaceutical around then

Filed or reported within 30 days of the trade day · 03/01~04/30

Ultragenyx Pharmaceutical's other lobbying reports